Nicole Holden


Nicole Holden


Philadelphia | Cira Centre, 2929 Arch Street, Philadelphia, PA, United States of America 19104-2808
+1 215 994 2936 | +1 215 994 2222


Nicole Holden focuses her practice on corporate and securities matters. Ms. Holden represents private equity sponsors and their portfolio companies as well as strategic buyers and sellers in merger and acquisition transactions across a wide range of industry sectors. She also represents companies and investment banks in domestic and cross-border securities offerings of equity and debt. In addition, Ms. Holden advises clients on general corporate matters, including corporate governance.

  • The Pennsylvania State University Schreyer Honors College, B.A., 2013, Honors and High Distinction, Phi Beta Kappa
  • Villanova University Charles Widger School of Law, J.D., 2016, magna cum laude, Order of the Coif, Herman J. Obert Award, Articles Editor of the Villanova Law Review
  • Pennsylvania

Mergers & Acquisitions

  • Court Square Capital Partners in its acquisition of Getaroom, a business-to-business hotel and vacation rental provider.
  • MSD Partners, L.P. in its acquisition of Ring Container Technologies, a leader in the plastic container manufacturing industry.
  • Travel Leaders Group, a travel management company managing leisure, business and franchise travel operations under a variety of diversified divisions and brands, in several acquisition transactions and related financing activities.
  • B&G Foods, Inc. in its acquisition of Back to Nature Foods Company, L.L.C.

Capital Markets & Corporate Finance

  • Underwriters, led by JP Morgan and Goldman Sachs, in connection with numerous public offerings of common stock by Amicus Therapeutics, Inc. (NASDAQ: FOLD), a biopharmaceutical company focused on rare genetic diseases.
  • Underwriters led by Piper Jaffray & Co. in connection with a follow-on offering by Recro Pharma, Inc. (NASDAQ: REPH), a revenue-generating, specialty pharmaceutical company primarily focused on developing innovative products for hospitals and ambulatory care settings.
  • Underwriters, led by Piper Jaffray & Co. and Stifel, in connection with a confidentially marketed public offering of common stock by Inovio Pharmaceuticals, Inc. (NYSE MKT: INO), a biopharmaceutical company focused on synthetic vaccines.